Photo from wikipedia
Prospective studies, mostly from Europe and North America, suggest that serum 25‐hydroxyvitamin D (25(OH)D) is inversely associated with mortality and cardiovascular disease (CVD) risk. Data from other regions are limited,… Click to show full abstract
Prospective studies, mostly from Europe and North America, suggest that serum 25‐hydroxyvitamin D (25(OH)D) is inversely associated with mortality and cardiovascular disease (CVD) risk. Data from other regions are limited, and threshold levels for adverse cardiovascular outcomes are uncertain. We examined serum 25(OH)D as a predictor of total mortality and cardiovascular outcomes in an Australian cohort.
Keywords:
serum hydroxyvitamin;
predictor;
mortality cardiovascular;
serum
Journal Title: Clinical Endocrinology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical Endocrinology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!